NCT01690442

Brief Summary

The proposed study addresses a significant public health threat of HIV, HCV and other STIs among a very high risk population of active IDUs and their sexual partners in Kazakhstan a region that is experiencing one of the fastest rising HIV epidemics in the world. There is a race to develop and implement effective HIV preventive interventions for IDUs and their sexual partners to stem the spread of HIV, HCV and other STIs in Almaty, Shu and other Central Asian towns along drug trafficking routes. The proposed study will test the effectiveness of a couplesbased HIV/STI risk reduction intervention to decrease new cases of HIV and Hepatitis C (HCV) and incidence of sexually transmitted infections (STIs), as well as to reduce unsafe injection practices and increase condom use among injecting drug users (IDUs) and their heterosexual, intimate partners in Kazakhstan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for phase_2 hiv

Timeline
Completed

Started May 2008

Longer than P75 for phase_2 hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

September 19, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 21, 2012

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

February 27, 2014

Status Verified

February 1, 2014

Enrollment Period

4.5 years

First QC Date

September 19, 2012

Last Update Submit

February 25, 2014

Conditions

Keywords

HIVAIDSPrevention

Outcome Measures

Primary Outcomes (4)

  • The proportion of condom protected acts of vaginal and anal intercourse

    12 months

  • The number of incidents of unclean syringes or needles in the past 90 days

    12 months

  • Proportion of injection acts in which unclean needles or syringes were used in the past 90 days

    12 months

  • The number of acts of unprotected vaginal and anal intercourse during the 90 days prior to the assessment period

    12 months

Secondary Outcomes (1)

  • Number of people participants shared needles or syringes with in the past 90 days

    12 months

Study Arms (2)

Couples Based HIV/STI Risk Reduction Intervention (CHSR)

EXPERIMENTAL

The intervention includes a combination of empowerment and couple self-efficacy building strategies, which are employed to help couples overcome resistance to risk reduction.

Behavioral: Couples Based HIV/STI Risk Reduction Intervention (CHSR)

Renaissance Wellness Promotion (WP)

ACTIVE COMPARATOR

This intervention employs a psychoeducational approach to promote wellness, focusing on: maintaining a healthy diet on a low budget, exercising and fitness, stress reducing strategies and specific health related issues that affect IDUs, such as overdose.

Behavioral: Renaissance Wellness Promotion (WP)

Interventions

The intervention includes a combination of empowerment and couple self-efficacy building strategies, which are employed to help couples overcome resistance to risk reduction.

Couples Based HIV/STI Risk Reduction Intervention (CHSR)

This intervention employs a psychoeducational approach to promote wellness, focusing on: maintaining a healthy diet on a low budget, exercising and fitness, stress reducing strategies and specific health related issues that affect IDUs, such as overdose.

Renaissance Wellness Promotion (WP)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Couples are eligible to participate if both partners are aged 18 or older
  • both partners identify each other as their main partner of the opposite sex and someone whom the participant considers a boy/girlfriend, spouse, lover and/ or parent of his/her child
  • the relationship has existed at least 3 months
  • each partner intends to remain together for at least 12 months
  • at least one partner reports having had unprotected vaginal or anal intercourse with the other partner at least once in the previous 90 days
  • at least one partner reports injecting drugs in the past 90 days
  • neither partner has plans to relocate beyond a reasonable distance from the study site

You may not qualify if:

  • Couples are excluded if either partner shows evidence of significant psychiatric, physical or neurological impairment that would limit effective participation as confirmed on a MiniMental State Examination and/or Quick Test
  • either partner reports severe physical violence perpetrated by the other partner in the past year on the Revised Conflict Tactics Scale
  • either partner is unable to commit to participate in the study through to completion
  • either partner reports that the couple is planning a pregnancy within the next 18 months
  • either partner is not fluent in Russian as determined during Informed Consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Global Health Research Center of Central Asia

Almaty, Kazakhstan

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Nabila El-Bassel

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Social Intervention Group, Global Health Research Center of Central Asia

Study Record Dates

First Submitted

September 19, 2012

First Posted

September 21, 2012

Study Start

May 1, 2008

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

February 27, 2014

Record last verified: 2014-02

Locations